Congenital microgastria

Congenital microgastria is an extremely rare developmental anomaly in which the stomach fails to develop to its normal size, resulting in a small, tubular, or rudimentary stomach. This condition arises from incomplete development of the dorsal mesogastrium during embryogenesis, typically around the fifth week of fetal development. The abnormally small stomach has significantly reduced capacity, which directly impairs the body's ability to receive, store, and process food. Congenital microgastria primarily affects the gastrointestinal system but can also be associated with anomalies in other organ systems, including the limbs, heart, and spleen (asplenia). It has been reported in association with VACTERL-like features and limb reduction defects, sometimes referred to as microgastria-limb reduction defect association. Key symptoms typically present in the neonatal or early infantile period and include feeding difficulties, frequent vomiting or gastroesophageal reflux, failure to thrive, early satiety, and postprandial discomfort due to the stomach's inability to accommodate normal volumes of food. Aspiration pneumonia may occur as a complication of severe reflux. Diarrhea related to rapid gastric emptying (dumping syndrome) can also be observed. The severity of symptoms depends on the degree of gastric hypoplasia and the presence of associated malformations. Management of congenital microgastria is primarily supportive and nutritional. Initial treatment often involves continuous or small-volume frequent feedings, sometimes requiring nasogastric or nasojejunal tube feeding. In more severe cases, surgical intervention may be necessary, including the creation of a gastric reservoir (Hunt-Lawrence pouch) using a jejunal loop to increase functional stomach capacity. This surgical approach has been shown to improve feeding tolerance and nutritional status. Long-term follow-up is essential to monitor growth, nutritional adequacy, and management of associated anomalies. There is no cure for the underlying developmental defect, and treatment remains focused on optimizing nutrition and managing complications.

Common questions about Congenital microgastria